medigraphic.com
ISSN 2007-4360 (Print)
Asociación Mexicana de Periodontología, Colegio de Periodoncistas A.C

2013, Number 3

<< Back

Rev Mex Periodontol 2013; 4 (3)

Phenotypes of periodontally compromised patients with Down syndrome. Part 1

Robredo C, Zerón A

Language: Spanish
References: 41
Page: 123-130
PDF size: 336.42 Kb.


ABSTRACT

Down’s syndrome appears like a chromosomal alteration that comes from the result of excess in genetic material; this includes a variety of physical and mental problems such as: health issues like, ear and eye problems, digestive, also mental illnesses, thyroid mal functioning and esqueletal issues such as: over sized head, or very small, over sized eyes, face and other body parts, sometimes they show hands with very short fingers sometimes they just have a single articulation in the fingers. The severity of these issues is different in every person. The periodontal inflammation is severe in almost every patient with Down’s syndrome due to the deficiency of the immune system. In different studies around the world it was probed that the patients with Down’s syndrome are more susceptible to present periodontal problems for the deficient immune system which bring this patients for a host more susceptible to all kinds of pathogenic bacteria, that take care of fill the tissues and bring the periodontal disease that ends in the loss of the denture, that’s why is recommended the care and control of risk factors of this patients for a professional and also by a person who takes care of this patients to learn and to teach themes to how to do a perfect cleaning.


REFERENCES

  1. Down JLH. Observation on at ethnic classification of idiots. Clin Lect Rep Lind Hop. 1866; 3: 259-263.

  2. Lejeune J, Gautier M, Turpin R. Etude des chromosomes somatiques de neuf enfants mongoliens. C R Acad Sci. 1959; 248: 1721-1722.

  3. Galley R. Medical management of the adult patient with Down syndrome. JAAPA. 2005; 18 (4): 45-52.

  4. Desai SS. Down syndrome: a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endon. 1997; 84 (3): 279-285.

  5. Frydman A, Nowzari H. Down syndrome-associated periodontitis: a critical review of the literature. Ompend Contin Educ Dent. 2012; 33 (5): 356-361.

  6. Véliz LM. Prevalencia de la enfermedad periodontal en niños con síndrome de Down. Odontolsanmarquina. 1998; 1 (1): 31-33.

  7. National Down syndromes Society. Information topics. Website: http://www.ndss.org/Resources/Research/Directory-of-Current-Studies/

  8. Oster J, Mikkelsen M, Nielsen A. Mortality and life-table in Down's syndrome. Acta Paediatr Scand. 1975; 64: 322-326.

  9. Ugazio AG, Maccario R, Motarangelo LD et al. Immunology of Down syndrome: a review. Am J Med Genet. 1990; 7: 204-212.

  10. Hennequin M, Faulks D, Veyrune JL, Bourdiol P. Significance of oral health in persons with Down syndrome: a literature review. Dev Med Child Neurol. 1999; 41: 275-283.

  11. Roizen NJ, Patterson D. Down’s syndrome. Lancet. 2003; 361: 1281-1289.

  12. Cichon P, Crawford L. Early-onset periodontitis associated with Down’s syndrome-a clinical interventional study. Department of Periodontology. Germany Periodontol: University of Witten/Herdecke, Witten; 1998.

  13. Benda CE. Mongolism and cretinism. New York: Grune and Stratton; 1949.

  14. Hanookai D, Nowzari H, Contreras A. Herpes viruses and periodontopathic bacteria in trisomy 21 periodontitis. J Periodontol. 2000; 71: 376-384.

  15. Cohen MM, Winer RA, Schwartz S, Shklar G. Oral aspects of mongolism. Part I. Periodontal disease in mongolism. Oral Surg Oral Med Oral Pathol. 1961; 14: 92-107.

  16. Saxén L, Aula S, Westermarck T. Periodontal disease associated with Down’s syndrome: an orthopantomographic evaluation. J Periodontol. 1977; 48: 337-340.

  17. Gronowicz G, Hadjimichael J, Richards D, Cerami A, Rossomando EF. Correlation between tumor necrosis factor-induced cytoskeletal changes and human collagenase gene induction. J Periodontol Res. 1992; 27: 562-568.

  18. Cohen MM, Winer RA. Dental and Facial Characteristics in Down's Syndrome (Mongolism). J Dent Res. 1965; 44: 197-208.

  19. Mehta PD, Dalton AI, Mehta SP, Percy ME, Sersen EA, Wisniewski HM. Immunoglobulin G subclasses in older persons with Down syndrome. J Neurolog Sei. 1993; 117: 186-191.

  20. Taylor GM, Haigh H, Williams AD, Souza SW, Harris R. Down’s syndrome lymphoid cell lines exhibit increased adhesion due to the over-expression of lymphocyte function-associated antigen (LFA-1). Immunology. 1988; 64: 451-456.

  21. McMillan BC, Hanson RP, Golubjatnikov R, Sinha SK. The effect of institutionalization on elevated IgD and IgG levels in patients with Down’s syndrome. J Ment Defic Res. 1975; 19: 209-223.

  22. Murakami J, Kato T, Kawai S, Akiyama S, Amano A, Morisaki I. Cellular motility of down syndrome gingival fibroblasts is susceptible to impairment by Porphyromonas gingivalis invasion. J Periodontol. 2008; 79: 721-727.

  23. Hann HL, Deacon JC, London WT. Lymphocyte surface markers and serum immunoglobins in persons with Down’s syndrome. Is J Ment Defic. 1979; 84: 245-251.

  24. Philip R, Berger AC, McManus NH et al. Abnormalities of the in vitro cellular and humoral responses to tetanus and influenza antigens with concomitant numerical alterations in lymphocyte subsets in Down’s syndrome. J Immunol. 1986; 136: 1661-1667.

  25. Caton J. Periodontal diagnosis and diagnostic aids. In: Proceedings of the world workshop in Clinical Periodontics. Chicago: The American Academy of Periodontology; 1989: pp. 11-122.

  26. Heitz-Mayfield LJ, Trombelli L, Heitz F, Needleman I, Moles D. A systematic review of the effect of surgical debridement versus non-surgical debridement for the treatment of chronic periodontitis. J Clin Periodontol. 2002; 29: 92-102.

  27. Cheng RH, Leung WK, Corbet EF. Non-surgical periodontal therapy with adjunctive chlorhexidine use in adults with down syndrome: a prospective case series. J Periodontol. 2008; 79: 379-385.

  28. Zaldívar-Chiapa RM, Arce-Mendoza AY, De La Rosa-Ramírez M, Caffesse RG, Solís-Soto SM. Evaluation of surgical and non-surgical periodontal therapies, and immunological status, of young down’s syndrome patients. J Periodontol. 2005; 76: 1061-1066.

  29. Modeer T, Barr M, Dahllöf G. Periodontal disease in children with Down’s syndrome. Scand J Dent Res. 1990; 98: 228-234.

  30. Nakagawa I, Inaba H, Yamamura T et al. Invasion of epithelial cells and proteolysis of cellular focal adhesion components by distinct fimbria types of Porphyromonas gingivalis. Infect Immun. 2006; 74: 3773-3782.

  31. Cutress TW. Periodontal disease and oral hygiene in trisomy 21. Oral Biology. 1971; 16 (11): 1345-1355.

  32. Khocht A, Yaskell T, Janal M, Turner BF, Rams TE, Haffajee AD et al. Subgingival microbiota in adult Down syndrome periodontitis. J Periodont Res. 2012; doi: 10.1111/j.1600-0765.

  33. Santos R, Shanfel J, Casamassimo P. Serum antibody response to Actinobacillus actinomycetemcomitans in Down syndrome. Spec Care Dent. 1996; 16: 80-83.

  34. McMillan RS, Kashgarian M. Relation of human abnormalities of structure and function to abnormalities of the dentition II Mongolism. J Am Dent Assoc. 1961; 63: 368-373.

  35. Amano A, Kishima T, Akiyama S, Nakagawa I, Hamada S, Morisaki IS. Periodontopathic bacteria in children with Down syndrome. J Periodontol. 2000; 71 (2): 249-255.

  36. Amano A. Molecular interaction of Porphyromonas gingivalis with host cells: implication for the microbial pathogenesis of periodontal disease. J Periodontol. 2003; 74: 90-96.

  37. Kato T, Kawai S, Nakano K et al. Virulence of Porphyromonas gingivalis is altered by substitution of fimbria gene with different genotype. Cell Microbiol. 2007; 9: 753-765.

  38. Amano A. Disruption of epithelial barrier and impairment of cellular function by Porphyromonas gingivalis. Front Biosci. 2007; 12: 3965-3974.

  39. Caffesse RG, Quiñones CR. Polypeptide growth factors and attachment proteins in periodontal wound healing and regeneration. Periodontol 2000. 1993; 1: 69-79.

  40. Cichon P, Crawford L, Grimm WD. Early onset periodontitis associated with Down’s syndrome-clinical interventional study. Ann Periodontol. 1998; 3 (1): 370-380.

  41. Miller MF, Ship II. Periodontal disease in the institutionalized Mongoloid. J Oral Med. 1977; 32: 9-13.




2020     |     www.medigraphic.com